Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urodynamic Effects of Gisadenafil in Men with LUTS
NCT00408954Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) comparing Placebo with Gisadenafil (2 arms). Primary endpoint: Hypothesis generation on urodynamic effects. Started Mar 2007; status: completed.
02
Drugs
gisadenafil
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT00408954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408954.